載入...
The Effects of Angiotensin Blocking Agents on the Progression of Liver Fibrosis in the HALT-C Trial Cohort
BACKGROUND: Therapies that can slow the progression of liver fibrosis in chronic liver disease are needed. Evidence suggests that the renin-angiotensin system (RAS) contributes to inflammation and fibrosis in chronic liver disease. Both animal and limited human studies have shown that RAS inhibition...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3142358/ https://ncbi.nlm.nih.gov/pubmed/21136163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-010-1507-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|